Sign In
Buy APM
$1.09
+0.114 (+11.68%)
At Close: Jun 03, 2026
Why Is Aptorum (APM) Stock Up 346% Today?
11:28am, Wednesday, 06'th Mar 2024
Aptorum (NASDAQ: APM ) stock is rocketing higher on Wednesday after the biopharmaceutical company announced a merger agreement with YOOV Group. This will be a reverse merger that will see YOOV shareho
NEW YORK & LONDON--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company (“Aptorum”), and privately-held YOOV Group Holding Ltd. (“YOOV”) jointly ann
Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended June 30, 2023
04:30pm, Friday, 22'nd Dec 2023
NEW YORK & LONDON--(BUSINESS WIRE)--Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group” or the “Company”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs
Aptorum Group Limited Announces Results of 2023 Annual General Meeting of Shareholders
04:30pm, Thursday, 21'st Dec 2023
NEW YORK & LONDON--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in o
Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 20, 2023
11:00am, Thursday, 16'th Nov 2023
NEW YORK & LONDON--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in o
Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets
02:57am, Thursday, 10'th Aug 2023
NEW YORK--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group” or “Aptorum”), a clinical-stage biopharmaceutical company, announced that it has received an approval letter fro
Why Is Aptorum (APM) Stock Down 16% Today?
08:43am, Monday, 08'th May 2023
Aptorum (NASDAQ: APM ) stock is falling on Monday after the company received a delisting notice from the Nasdaq Stock Market LLC. The reason given for the delisting notice is Aptorum failing to mainta
Aptorum Group shares double after merger plans, earnings delight investors
12:41pm, Wednesday, 03'rd May 2023
Aptorum Group saw its market capitalization double following a busy week where the biopharmaceutical firm released its latest results and announced a merger plan. Shares of the Nasdaq-listed company w
Why Is Aptorum (APM) Stock Up 166% Today?
07:55am, Wednesday, 03'rd May 2023
Aptorum (NASDAQ: APM ) stock is climbing higher on Wednesday despite a lack of news from the clinical-stage biopharmaceutical company. However, trading of APM stock is taking off today with more than
Aptorum Group Launches NativusWell®, a Novel Nutraceutical for Menopause, in China
06:10pm, Friday, 03'rd Mar 2023
NEW YORK & LONDON & PARIS–(BUSINESS WIRE)–Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group”), a clinical-stage biopharmaceutical company focused on the
7 Hot Small-Cap Stocks to Buy in September
06:45am, Friday, 02'nd Sep 2022
In general, finding small-cap stocks to buy can be somewhat fraught. These are stocks with market capitalizations between roughly $300 million and $2 billion.
Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022
08:31pm, Thursday, 25'th Aug 2022
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, au
Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 – 26 2022
08:13am, Tuesday, 17'th May 2022
NEW YORK & LONDON & PARIS--(BUSINESS WIRE)--Regulatory News: Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) a clinical stage biopharmaceutical company dedicated to meeting unmet medical need
Aptorum Group: Advancing Oncology, Autoimmune & Infectious Disease Therapies
08:09pm, Friday, 11'th Feb 2022 Seeking AlphaAptorum Group: Advancing Oncology, Autoimmune & Infectious Disease Therapies
03:09pm, Friday, 11'th Feb 2022
Aptorum Group is advancing therapeutic programs to serve unmet needs in orphan oncology diseases, infectious diseases, metabolic diseases, women's health and other areas.
